We all welcome the fact that Orkambi will now be able to be provided in this country under the NHS, and we thank those who campaigned for it. The shame is that we are not told what the deal is with the company concerned. As for the fabled 40 hospitals, that figure dropped to 20 and then finally dropped to six.
We learned this week that Government officials have met US pharmaceutical companies five times as part of the Prime Minister’s planned trade deal. The US has called for “full market access” to our NHS, which would mean prices of some of our most important medicines increasing by up to sevenfold. While the Government are having secret meetings with US corporations, it is patients here who continue to suffer. Can the Prime Minister explain why the number of people waiting longer for urgent cancer treatment has tripled over the past nine years?